Jason Megson, an equity derivatives trader at CDC IXIS North America in New York, has left the firm. Megson, who could not be reached, is not yet thought to have joined a competitor. His departure follows Quincy Evans and Christophe Thomas, who co-headed the firm's convertible arbitrage effort (DW, 7/13). Janine Shagoury, spokeswoman in New York, declined comment.
Megson reported to Vuk Bulajic, head of equity derivatives at CDC in New York, who was on vacation and could not be reached.